Despite COVID-19, pharma R&D funding at all-time high: IQVIA
Outsourcing Pharma
JUNE 1, 2021
According to the clinical research solutions firm, disruptions due to the pandemic did not stop the industry from fueling R&D at unprecedented levels.
79 
Innovation in insulin delivery: Two companies look to transform diabetes treatment
BioPharma Reporter
FEBRUARY 16, 2022
Multiple pharma R&D teams are seeking to transform how diabetes treatment is managed.
Pharma R&D investment report shows positive signs: Deloitte
Outsourcing Pharma
JANUARY 14, 2022
According to the companyâs 12th Annual Pharmaceutical Innovation Report, pharmaceutical R&D return on investment has climbed to its highest peak since 2014.
Let's personalize your content